Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancersSandra Misale, Alberto Bardelli, Ivana Božić et al.|Nature Communications|2015Cited by 128
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Richard Sullivan, Carlo La Vecchia et al.|The Lancet Oncology|2022Cited by 104
<i>BRAF</i> V600E Is a Determinant of Sensitivity to Proteasome InhibitorsDavide Zecchin, Federica Di Nicolantonio|Molecular Cancer Therapeutics|2013Cited by 20